These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2257227)

  • 1. Reduced nuclear binding of a DNA minor groove ligand (Hoechst 33342) and its impact on cytotoxicity in drug resistant murine cell lines.
    Morgan SA; Watson JV; Twentyman PR; Smith PJ
    Br J Cancer; 1990 Dec; 62(6):959-65. PubMed ID: 2257227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased uptake of vital dye Hoechst 33342 during S phase in synchronized HeLa S3 cells.
    Frankfurt OS
    Cytometry; 1983 Nov; 4(3):216-21. PubMed ID: 6661988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer.
    Morgan SA; Watson JV; Twentyman PR; Smith PJ
    Br J Cancer; 1989 Sep; 60(3):282-7. PubMed ID: 2477051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mammalian cell mutant with enhanced capacity to dissociate a bis-benzimidazole dye-DNA complex.
    Smith PJ; Lacy M; Debenham PG; Watson JV
    Carcinogenesis; 1988 Mar; 9(3):485-90. PubMed ID: 3345586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells.
    Lalande ME; Ling V; Miller RG
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):363-7. PubMed ID: 6941251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new human breast carcinoma cell line resistant to DNA-damaging drugs.
    Levina VV; Drobchenko EA; Shabalina EV
    Altern Lab Anim; 2004 Oct; 32(4):391-9. PubMed ID: 15651924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of multidrug resistance and quantification of responses of human tumour cells to cytotoxic agents using flow cytometric spectral shift analysis of Hoechst 33,342-DNA fluorescence.
    Smith PJ; Morgan SA; Watson JV
    Cancer Chemother Pharmacol; 1991; 27(6):445-50. PubMed ID: 1849464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance mechanism development to the topoisomerase-I inhibitor Hoechst 33342 by Leishmania donovani.
    Marquis JF; Hardy I; Olivier M
    Parasitology; 2005 Aug; 131(Pt 2):197-206. PubMed ID: 16145936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequence of Hoechst 33342-mediated Leishmania DNA topoisomerase-I inhibition on parasite replication.
    Marquis JF; Drolet M; Olivier M
    Parasitology; 2003 Jan; 126(Pt 1):21-30. PubMed ID: 12613760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human leukemia cells with multidrug-resistance phenotype using multilabeling with fluorescent dyes.
    Lautier D; Lahmy S; Canitrot Y; Vigo J; Viallet P; Salmon JM
    Anticancer Res; 1993; 13(5A):1557-63. PubMed ID: 8239535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A.
    Larrivée B; Averill DA
    Cancer Chemother Pharmacol; 2000; 45(3):219-30. PubMed ID: 10663640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.
    Canitrot Y; Lahmy S; Buquen JJ; Canitrot D; Lautier D
    Cancer Lett; 1996 Aug; 106(1):59-68. PubMed ID: 8827047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of DNA topoisomerases in the active dissociation of DNA minor groove-ligand complexes. A flow cytometric study of inhibitor effects.
    Smith PJ; Debenham PG; Watson JV
    Mutat Res; 1989 Mar; 217(2):163-72. PubMed ID: 2537463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
    Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
    Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA topoisomerase II-independent route for novobiocin-mediated resistance to DNA binding agents.
    Smith PJ; Bell SM
    Cancer Chemother Pharmacol; 1990; 26(4):257-62. PubMed ID: 2164457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
    Smith PJ; Bell SM; Dee A; Sykes H
    Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FACS analysis of a hyperthermia-induced alteration in Hoechst 33342 permeability and direct measurement of its relationship to cell survival.
    Rice GC; Gray JW; Dewey WC
    J Cell Physiol; 1985 Mar; 122(3):387-96. PubMed ID: 3968193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "DNA clearing" from non-covalently bound agents in mammalian cells as a new mechanism of drug resistance.
    Levina VV; Varfolomeeva EY; Filatov MV
    Membr Cell Biol; 1999; 12(6):883-93. PubMed ID: 10512056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeling nuclear DNA with hoechst 33342.
    Chazotte B
    Cold Spring Harb Protoc; 2011 Jan; 2011(1):pdb.prot5557. PubMed ID: 21205857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.